Treatment of Parental Anxiety Virtual Reality (VR)
- Conditions
- AnxietyVirtual RealityParents
- Registration Number
- NCT05729347
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and pediatric populations
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
- Ages 18-99 (Patient's parents will be enrolled)
- Able to consent
- People who do not consent
- Significant Cognitive Impairment
- History of Severe Motion Sickness
- Current Nausea
- Seizures
- Visual Problems Patients whose children are clinically unstable or require urgent/emergent intervention
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Procedural-Related Anxiety Duration of intervention, approximately 20-30 minutes Validated questionnaires regarding anxiety will be administers pre- and post-intervention (i.e virtual reality) and compared to those in the control arm (i.e no virtual reality)
- Secondary Outcome Measures
Name Time Method State-Trait Anxiety Inventory baseline, immediately after the intervention The State-Trait Anxiety Inventory (STAI) is a validated self-report questionnaire consisting of two subscales that measure state anxiety (temporary condition) and trait anxiety (general tendency). Each subscale contains 20 items rated on a 4-point Likert scale. Scores range from 20 to 80 per subscale, with higher scores indicating greater anxiety.
Device satisfaction immediately after intervention To evaluate the overall impact of device satisfaction, participants will complete the self-developed satisfaction survey. Participants will rank each factor on a Likert scale from 1 = not at all to 5 = a lot.
Modified Pain Catastrophizing Scale immediately after intervention Modified Pain Catastrophizing Scale(PCS); It is a self-report measure adapted from the Adult Pain Catastrophizing Scale used to assess negative thinking associated with pain. It contains 3 items rated on a 5-point scale ranging from 0 = "not at all" to 4 = "very much".
Change in anxiety levels baseline, immediately after the intervention Anxiety level measured by a Visual Analogue Scale - Anxiety (VAS-A) ranging from 0-10. Scale ranges from 0-10, with higher scores indicating higher anxiety levels.
Trial Locations
- Locations (1)
Lucile Parkard Children's Hospital
🇺🇸Stanford, California, United States
Lucile Parkard Children's Hospital🇺🇸Stanford, California, United StatesThomas J Caruso, MD, PhDContact